Search research articles
Contact Us
Filters
Showing results (121-130 of 133) with videos related to
Page
of 14
Sort By:
Annals of Surgery
|
June 16, 2021
Chemotherapy Versus Chemotherapy Plus Chemoradiation as Neoadjuvant Therapy for Resectable Gastric Adenocarcinoma: A Multi-institutional Analysis
Casey J Allen, David T Pointer, Alisa N Blumenthaler, et al.
The Journal of Clinical Investigation
|
June 26, 2010
Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice
Ken L Chambliss, Qian Wu, Sarah Oltmann, et al.
JAMA Network Open
|
May 25, 2022
Development and Validation of an Explainable Machine Learning Model for Major Complications After Cytoreductive Surgery
Huiyu Deng, Zahra Eftekhari, Cameron Carlin, et al.
Annals of Surgical Oncology
|
February 3, 2024
Preoperative CA 19-9 Predicts Disease Progression in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Analysis from the US HIPEC Collaborative
Nadege T Fackche, Ryan K Schmocker, Richard Nudotor, et al.
Annals of Surgical Oncology
|
June 9, 2023
Validation of the AJCC 8th Edition Staging System for Disseminated Appendiceal Cancer Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Multi-institutional Analysis
Gopika SenthilKumar, Anai N Kothari, Ugwuji N Maduekwe, et al.
Annals of Surgical Oncology
|
October 19, 2020
CRS/HIPEC with Major Organ Resection in Peritoneal Mesothelioma Does not Impact Major Complications or Overall Survival: A Retrospective Cohort Study of the US HIPEC Collaborative
David Roife, Benjamin D Powers, Mohammad Y Zaidi, et al.
Annals of Surgical Oncology
|
January 28, 2021
Impact of Perioperative Blood Transfusions on Outcomes After Hyperthermic Intraperitoneal Chemotherapy: A Propensity-Matched Analysis
Boateng Kubi, Richard Nudotor, Nadege Fackche, et al.
Annals of Surgical Oncology
|
April 23, 2020
Repeat Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Not Associated with Prohibitive Complications: Results of a Multiinstitutional Retrospective Study
Benjamin D Powers, Seth Felder, Jula Veerapong, et al.
Annals of Surgical Oncology
|
August 24, 2023
Neighborhood-Level Socioeconomic Disadvantage Predicts Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignancy
Nolan M Winicki, Shannon N Radomski, Isabella S Florissi, et al.
Journal of Clinical Medicine
|
March 14, 2020
Impact of Neoadjuvant Chemotherapy on the Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Multi-Institutional Retrospective Review
Eliza W Beal, Lorena P Suarez-Kelly, Charles W Kimbrough, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 133) with videos related to
Sort By:
Page
of 14
Annals of Surgery
|
June 16, 2021
Chemotherapy Versus Chemotherapy Plus Chemoradiation as Neoadjuvant Therapy for Resectable Gastric Adenocarcinoma: A Multi-institutional Analysis
Casey J Allen, David T Pointer, Alisa N Blumenthaler, et al.
The Journal of Clinical Investigation
|
June 26, 2010
Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice
Ken L Chambliss, Qian Wu, Sarah Oltmann, et al.
JAMA Network Open
|
May 25, 2022
Development and Validation of an Explainable Machine Learning Model for Major Complications After Cytoreductive Surgery
Huiyu Deng, Zahra Eftekhari, Cameron Carlin, et al.
Annals of Surgical Oncology
|
February 3, 2024
Preoperative CA 19-9 Predicts Disease Progression in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Analysis from the US HIPEC Collaborative
Nadege T Fackche, Ryan K Schmocker, Richard Nudotor, et al.
Annals of Surgical Oncology
|
June 9, 2023
Validation of the AJCC 8th Edition Staging System for Disseminated Appendiceal Cancer Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Multi-institutional Analysis
Gopika SenthilKumar, Anai N Kothari, Ugwuji N Maduekwe, et al.
Annals of Surgical Oncology
|
October 19, 2020
CRS/HIPEC with Major Organ Resection in Peritoneal Mesothelioma Does not Impact Major Complications or Overall Survival: A Retrospective Cohort Study of the US HIPEC Collaborative
David Roife, Benjamin D Powers, Mohammad Y Zaidi, et al.
Annals of Surgical Oncology
|
January 28, 2021
Impact of Perioperative Blood Transfusions on Outcomes After Hyperthermic Intraperitoneal Chemotherapy: A Propensity-Matched Analysis
Boateng Kubi, Richard Nudotor, Nadege Fackche, et al.
Annals of Surgical Oncology
|
April 23, 2020
Repeat Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Not Associated with Prohibitive Complications: Results of a Multiinstitutional Retrospective Study
Benjamin D Powers, Seth Felder, Jula Veerapong, et al.
Annals of Surgical Oncology
|
August 24, 2023
Neighborhood-Level Socioeconomic Disadvantage Predicts Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignancy
Nolan M Winicki, Shannon N Radomski, Isabella S Florissi, et al.
Journal of Clinical Medicine
|
March 14, 2020
Impact of Neoadjuvant Chemotherapy on the Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Multi-Institutional Retrospective Review
Eliza W Beal, Lorena P Suarez-Kelly, Charles W Kimbrough, et al.
Page
of 14